• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

“It's not something that's really been brought up”: Opportunities and challenges for ongoing advance care planning discussions among individuals living with mechanical circulatory support
Advance care planning (ACP) among individuals living with a mechanical circulatory support (MCS) device is complex as the trajectory is typified by recurring life-threatening complications with a limited three-year survival rate of 57%.1 Additionally, 89.2% of MCS patients report experiencing complications such as gastrointestinal bleeding, stroke, and sepsis.2 –4 Against this background, in 2013, the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission required MCS teams to include palliative care consultations to enhance ACP communication early in the trajectory, specifically during the evaluation for MCS surgery.
Source: Heart and Lung - March 23, 2022 Category: Intensive Care Authors: Tiffany Dzou, Jaime D. Moriguchi, Lynn Doering, Jo-Ann Eastwood, Carol Pavlish, Huibrie C. Pieters Source Type: research

Medical Management of Left Ventricular Assist Device Patients: A Practical Guide for the Nonexpert Clinician
This article provides a concise overview of the medical management of LVAD patients for nonexpert clinicians. Our presentation includes the basics of LVAD physiology, design, and operation, patient selection and assessment, medical management, adverse event identification and management, multidisciplinary care, and management of special circumstances, such as noncardiac surgery, cardiac arrest, and end-of-life care. The clinical examination of LVAD patients is unique in terms of blood pressure and heart rate assessment, LVAD “hum” auscultation, driveline and insertion site inspection, and device parameter recording. Im...
Source: Canadian Journal of Cardiology - February 7, 2020 Category: Cardiology Source Type: research

Medical Management of LVAD Patients: A Practical Guide for the Non-Expert Clinician
This article provides a concise overview of the medical management of LVAD patients aimed for non-expert clinicians. Our presentation includes the basics of LVAD physiology, design and operation, patient selection, patient assessment, medical management, adverse event identification and management, multidisciplinary care, and management of special circumstances such as non-cardiac surgery, cardiac arrest, and end-of-life care. The clinical examination of LVAD patients is unique in terms of blood-pressure and heart-rate assessment, LVAD ‘hum’ auscultation, driveline/insertion-site inspection, and device-parameter record...
Source: Canadian Journal of Cardiology - October 5, 2019 Category: Cardiology Source Type: research

Cochrane ' s 30 under 30: Ndi Euphrasia Ebai-Atuh
Cochrane is made up of  13,000 members and over 50,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane as researchers, citizen scientists...
Source: Cochrane News and Events - April 12, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Palliative Care Clinicians Caring for Patients Before and After Continuous Flow-Left Ventricular Assist Device
Left ventricular assist devices (LVADs) are an available treatment option for carefully-selected patients with advanced heart failure. Initially developed as a bridge to transplantation, LVADs are now also offered to patients ineligible for transplantation as destination therapy (DT). Individuals with a DT-LVAD will live the remainder of their lives with the device in place. While survival and quality of life improve with LVADs compared to medical therapy, complications persist including bleeding, infection, and stroke.
Source: Journal of Pain and Symptom Management - July 12, 2017 Category: Palliative Care Authors: Sara E. Wordingham, Colleen K. McIlvennan, Timothy J. Fendler, Amy L. Behnken, Shannon M. Dunlay, James N. Kirkpatrick, Keith M. Swetz Source Type: research

Interventional radiology in the head and neck region.
Authors: Mayer C, Hattingen E, Schild H, Bootz F, Schröck A Abstract In interventional neuroradiology, endovascular embolization represents an important and helpful tool in the treatment of multiple head and neck diseases. These interventional procedures may be performed with curative intent, to reduce the surgical risk within a multimodal treatment concept, or to improve or at least maintain a good quality of life within a palliative therapy concept. In addition to a good understanding of disease pathology, knowledge of vascular anatomy, including collateral vessels and dangerous extracranial-intracranial anast...
Source: HNO - April 30, 2017 Category: ENT & OMF Tags: HNO Source Type: research

A Woman's Place is at the Table
As I watched Donald Trump pace behind Hillary Clinton during the second presidential debate, I noticed myself growing increasingly uncomfortable. At the time, I attributed my discomfort to the generalized anxiety accompanying this particularly contentious election cycle. It was only when I saw the Saturday Night Live parody of that debate that I realized what had truly spooked me. It was the way Alec Baldwin, playing Donald Trump, lurked menacingly behind Kate McKinnon, playing Hillary Clinton, throughout the event. It was on his final swerve across the frame, to the soundtrack of Jaws, that I understood the source of my d...
Source: Healthy Living - The Huffington Post - November 2, 2016 Category: Consumer Health News Source Type: news

Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices
Within the last decade, advancements in left ventricular assist device therapy have allowed patients with end-stage heart failure (HF) to live longer and with better quality of life. Like other life-saving interventions, however, there remains the risk of complications including infections, bleeding episodes, and stroke. The candidate for left ventricular assist device therapy faces complex challenges going forward, both physical and psychological, many of which may benefit from the application of palliative care principles by trained specialists.
Source: The American Journal of Cardiology - June 20, 2016 Category: Cardiology Authors: Nancy Luo, Joseph G. Rogers, Gwen C. Dodson, Chetan B. Patel, Anthony N. Galanos, Carmelo A. Milano, Christopher M. O'Connor, Robert J. Mentz Tags: Heart Failure Source Type: research

In people with atrial fibrillation receiving antithrombotics, short-term non-steroidal anti-inflammatory drug exposure increases risk of serious bleeding
Commentary on: Lamberts M, Lip GYH, Hansen ML, et al. Relation of non-steroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy Ann Intern Med 2014;161:690–8. Implications for practice and research Short courses of non-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution in patients with atrial fibrillation (AF) already taking antithrombotic therapy for stroke prevention since there is an increased risk of serious bleeding and clot formation. Research needs to be carried out on whether combined NSAID and non-v...
Source: Evidence-Based Nursing - December 15, 2015 Category: Nursing Authors: Myat, A. Tags: GI bleeding, Adult nursing, Drugs: cardiovascular system, Pain (neurology), Stroke, Ischaemic heart disease, Pain (palliative care), Pain (anaesthesia), Drugs: musculoskeletal and joint diseases, Arrhythmias Source Type: research

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer
Discussion: Although systemic thrombolysis with tPA for ischemic stroke in patients with advanced-stage cancer may be performed relatively safely, optimal post-thrombolysis management is important to prevent the complications.Case Rep Neurol 2014;6:238-242
Source: Case Reports in Neurology - November 7, 2014 Category: Neurology Source Type: research

Fatigue in Healthy and Diseased Individuals.
CONCLUSIONS: Fatigue needs to be recognized as an important condition that is not only a symptom but may also be quantified and can be modified by various measures depending on the underlying cause. PMID: 23892338 [PubMed - as supplied by publisher]
Source: The American Journal of Hospice and Palliative Care - July 26, 2013 Category: Palliative Care Authors: Finsterer J, Mahjoub SZ Tags: Am J Hosp Palliat Care Source Type: research